| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 7, 731-742, Copyright © 1993 by Endocrine Society
ARTICLES |
SK Nordeen, BJ Bona and ML Moyer
Department of Pathology (B216), University of Colorado Health Sciences Center, Denver 80262.
RU486 is a glucocorticoid and progesterone antagonist. In glucocorticoid-responsive fibroblasts, it mediates little or no induction of a truncated, hormone-responsive mouse mammary tumor virus promoter; moreover, it abrogates the induction mediated by the glucocorticoid agonist, dexamethasone. However, when the fibroblasts are treated with activators of protein kinase A, 8-Br-cAMP or forskolin, along with RU486, the steroid now acts as a partial agonist, capable of mediating an induction of hormone-responsive reporter genes. In addition, the ability of RU486 to block the action of the glucocorticoid agonist, dexamethasone, is compromised by concomitant treatment with 8-Br-cAMP. Activators of protein kinase C fail to elicit these phenomena. Induction of gene expression in the presence of 8-Br- cAMP is dependent on the dose of RU486 over a range consistent with a glucocorticoid receptor-mediated mechanism. An antagonist, ZK98 299, which unlike RU486 is not thought to permit receptor binding to DNA, is not activated by 8-Br-cAMP. The elicitation of RU486 agonist activity cannot be attributed solely to idiosyncrasies of the cell line or the promoter. Similar phenomena are observed in another glucocorticoid- responsive fibroblast line. Furthermore, RU486 can induce a minimal promoter bearing two copies of a synthetic receptor target site. However, we have identified at least one promoter toward which RU486 still behaves as an antagonist despite 8-Br-cAMP treatment. These observations suggest that the unmasking of latent agonist activity in a type II antagonist is not an isolated phenomenon and may, therefore, be seen with other receptors and antagonists. The finding that modulation of cellular signal transduction pathways can unmask agonist activity in an otherwise effective steroid antagonist has significant implications for the use of steroid antagonists in the clinical setting and could represent a heretofore unrecognized mechanism for the development of steroid resistance.
This article has been cited by other articles:
 |
|
 |
|
  A. A. Goyeneche, R. W. Caron, and C. M. Telleria Mifepristone Inhibits Ovarian Cancer Cell Growth In vitro and In vivo Clin. Cancer Res., June 1, 2007; 13(11): 3370 - 3379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Roggero, A. R Perez, M. Tamae-Kakazu, I. Piazzon, I. Nepomnaschy, H. O Besedovsky, O. A Bottasso, and A. del Rey Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J. Endocrinol., August 1, 2006; 190(2): 495 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schmidt, S. Levine, M. S. Oitzl, M. van der Mark, M. B. Muller, F. Holsboer, and E. R. de Kloet Glucocorticoid Receptor Blockade Disinhibits Pituitary-Adrenal Activity during the Stress Hyporesponsive Period of the Mouse Endocrinology, March 1, 2005; 146(3): 1458 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Miller, H. L. Miller, A. van Bokhoven, J. R. Lambert, P. N. Werahera, O. Schirripa, M. S. Lucia, and S. K. Nordeen Aberrant HOXC Expression Accompanies the Malignant Phenotype in Human Prostate Cancer Res., September 15, 2003; 63(18): 5879 - 5888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Davidson, S. C. Dogra, and B. K. May The Antiglucocorticoid RU486 Inhibits Phenobarbital Induction of the Chicken CYP2H1 Gene in Primary Hepatocytes Mol. Pharmacol., August 1, 2001; 60(2): 274 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Knutti, A. Kaul, and A. Kralli A Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen Mol. Cell. Biol., April 1, 2000; 20(7): 2411 - 2422. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Fernandes, E. Guida, V. Koutsoubos, T. Harris, P. Vadiveloo, J. W. Wilson, and A. G. Stewart Glucocorticoids Inhibit Proliferation, Cyclin D1 Expression, and Retinoblastoma Protein Phosphorylation, but Not Activity of the Extracellular-Regulated Kinases in Human Cultured Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 77 - 88. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. PAZIRANDEH, Y. XUE, I. RAFTER, J. SJÖVALL, M. JONDAL, and S. OKRET Paracrine glucocorticoid activity produced by mouse thymic epithelial cells FASEB J, May 1, 1999; 13(8): 893 - 901. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. L. Grimm and S. K. Nordeen A Composite Enhancer Element Directing Tissue-specific Expression of Mouse Mammary Tumor Virus Requires both Ubiquitous and Tissue-restricted Factors J. Biol. Chem., April 30, 1999; 274(18): 12790 - 12796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. C-L. Lin, E. H. Ng, S. E. Aw, M. G-K. Tan, E. H-L. Ng, V. S-W. Chan, and G. H. Ho Progestins Inhibit the Growth of MDA-MB-231 Cells Transfected with Progesterone Receptor Complementary DNA Clin. Cancer Res., February 1, 1999; 5(2): 395 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lambert and S. K. Nordeen Steroid-selective Initiation of Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Is Controlled by the Site of Promoter Integration J. Biol. Chem., December 4, 1998; 273(49): 32708 - 32714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Grimm and S. K. Nordeen Mouse Mammary Tumor Virus Sequences Responsible for Activating Cellular Oncogenes J. Virol., December 1, 1998; 72(12): 9428 - 9435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Szabo, S. M. Kilen, S. Saberi, S. J. Ringstrom, and N. B. Schwartz Antiprogestins Suppress Basal and Activin-Stimulated Follicle-Stimulating Hormone Secretion in an Estrogen-Dependent Manner Endocrinology, May 1, 1998; 139(5): 2223 - 2228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Wagner, J. D. Norris, T. A. Knotts, N. L. Weigel, and D. P. McDonnell The Nuclear Corepressors NCoR and SMRT Are Key Regulators of Both Ligand- and 8-Bromo-Cyclic AMP-Dependent Transcriptional Activity of the Human Progesterone Receptor Mol. Cell. Biol., March 1, 1998; 18(3): 1369 - 1378. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Kahmann, L. Vaßen, and L. Klein-Hitpass Synergistic Enhancement of PRB-Mediated RU486 and R5020 Agonist Activities through Cyclic Adenosine 3',5'-Monophosphate Represents a Delayed Primary Response Mol. Endocrinol., February 1, 1998; 12(2): 278 - 289. [Abstract] [Full Text]
|
|
|
|
|
|
S. Hellbach, P. Gärtner, J. Deicke, D. Fischer, A. H. S. Hassan, and O. F. X. Almeida Inherent glucocorticoid response potential of isolated hypothalamic neuroendocrine neurons FASEB J, February 1, 1998; 12(2): 199 - 207. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Fryer, S. K. Nordeen, and T. K. Archer Antiprogestins Mediate Differential Effects on Glucocorticoid Receptor Remodeling of Chromatin Structure J. Biol. Chem., January 9, 1998; 273(2): 1175 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Ringstrom, M. Szabo, S. M. Kilen, S. Saberi, K. L. Knox, and N. B. Schwartz The Antiprogestins RU486 and ZK98299 Affect Follicle-Stimulating Hormone Secretion Differentially on Estrus, but not on Proestrus Endocrinology, June 1, 1997; 138(6): 2286 - 2290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Bai, B. G. Rowan, V. E. Allgood, B. W. O'Malley, and N. L. Weigel Differential Phosphorylation of Chicken Progesterone Receptor in Hormone-dependent and Ligand-independent Activation J. Biol. Chem., April 18, 1997; 272(16): 10457 - 10463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Massaad, M. Lombes, M. Aggerbeck, M.-E. Rafestin-Oblin, and R. Barouki Cell-Specific, Promoter-Dependent Mineralocorticoid Agonist Activity of Spironolactone Mol. Pharmacol., February 1, 1997; 51(2): 285 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Szapary, M. Xu, and S. S. Simons Jr. Induction Properties of a Transiently Transfected Glucocorticoid-responsive Gene Vary with Glucocorticoid Receptor Concentration J. Biol. Chem., November 29, 1996; 271(48): 30576 - 30582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Wang, H. J. Cao, V. D. Winn, L. J. Rezanka, Y. Frobert, C. H. Evans, D. Sciaky, D. A. Young, and T. J. Smith Leukoregulin Induction of Prostaglandin-Endoperoxide H Synthase-2 in Human Orbital Fibroblasts. AN IN VITRO MODEL FOR CONNECTIVE TISSUE INFLAMMATION J. Biol. Chem., September 13, 1996; 271(37): 22718 - 22728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oshima, D. Szapary, and S. S. Simons Jr. The Factor Binding to the Glucocorticoid Modulatory Element of the Tyrosine Aminotransferase Gene Is a Novel and Ubiquitous Heteromeric Complex J. Biol. Chem., September 15, 1995; 270(37): 21893 - 21901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wehling, C. B. Neylon, M. Fullerton, A. Bobik, and J. W. Funder Nongenomic Effects of Aldosterone on Intracellular Ca2+ in Vascular Smooth Muscle Cells Circ. Res., June 1, 1995; 76(6): 973 - 979. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Fryer, H. K. Kinyamu, I. Rogatsky, M. J. Garabedian, and T. K. Archer Selective Activation of the Glucocorticoid Receptor by Steroid Antagonists in Human Breast Cancer and Osteosarcoma Cells J. Biol. Chem., June 2, 2000; 275(23): 17771 - 17777. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
